- Home
- VERU vs SES Comparison
VERU vs SES Comparison
Compare VERU & SES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERU
- SES
- Stock Information
- Founded
- VERU 1971
- SES 2012
- Country
- VERU United States
- SES United States
- Employees
- VERU N/A
- SES N/A
- Industry
- VERU Biotechnology: Pharmaceutical Preparations
- SES Auto Parts:O.E.M.
- Sector
- VERU Health Care
- SES Consumer Discretionary
- Exchange
- VERU Nasdaq
- SES Nasdaq
- Market Cap
- VERU 107.2M
- SES 110.3M
- IPO Year
- VERU 1990
- SES N/A
- Fundamental
- Price
- VERU $0.74
- SES $2.25
- Analyst Decision
- VERU Strong Buy
- SES Sell
- Analyst Count
- VERU 4
- SES 2
- Target Price
- VERU $4.00
- SES $1.25
- AVG Volume (30 Days)
- VERU 1.6M
- SES 27.6M
- Earning Date
- VERU 02-06-2025
- SES 02-24-2025
- Dividend Yield
- VERU N/A
- SES N/A
- EPS Growth
- VERU N/A
- SES N/A
- EPS
- VERU N/A
- SES N/A
- Revenue
- VERU $16,886,419.00
- SES N/A
- Revenue This Year
- VERU N/A
- SES N/A
- Revenue Next Year
- VERU N/A
- SES N/A
- P/E Ratio
- VERU N/A
- SES N/A
- Revenue Growth
- VERU 3.62
- SES N/A
- 52 Week Low
- VERU $0.36
- SES $0.20
- 52 Week High
- VERU $1.92
- SES $2.47
- Technical
- Relative Strength Index (RSI)
- VERU 56.66
- SES 77.02
- Support Level
- VERU $0.63
- SES $1.84
- Resistance Level
- VERU $0.88
- SES $0.46
- Average True Range (ATR)
- VERU 0.09
- SES 0.28
- MACD
- VERU 0.00
- SES 0.19
- Stochastic Oscillator
- VERU 49.11
- SES 89.55
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.
About SES SES AI Corporation
SES AI Corp is a pre-commercialization stage company engaged in the development and initial production of high-performance Lithium-Metal (Li-Metal) rechargeable battery technologies for electric vehicles (EVs), urban air mobility (UAM), which encompasses electric vehicle take-off and landing (eVTOL), and other applications. The company is an integrated Li-Metal battery manufacturer with capabilities in material, cell, module, AI-powered safety algorithms, and recycling.